Patents by Inventor Michael Trauner

Michael Trauner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of nor-ursodeoxycholic acid for reducing liver fat
    Patent number: 11850252
    Abstract: The present invention relates to the use of Nor-UDCA in the treatment of hepatic steatosis in patients having a hepatic fat fraction of greater than 10%.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: December 26, 2023
    Assignee: DR. FALK PHARMA GMBH
    Inventors: Markus Pröls, Roland Greinwald, Michael Trauner, Peter Fickert
  • Use of Nor-Ursodeoxycholic Acid for Reducing Liver Fat
    Publication number: 20200246357
    Abstract: The present invention relates to the use of Nor-UDCA in the treatment of hepatic steatosis in patients having a hepatic fat fraction of greater than 10%.
    Type: Application
    Filed: September 28, 2018
    Publication date: August 6, 2020
    Inventors: Markus PRÖLS, Roland GREINWALD, Michael TRAUNER, Peter FICKERT
  • USE OF NOR-BILE ACIDS IN THE TREATMENT OF ARTERIOSCLEROSIS
    Publication number: 20200101084
    Abstract: The present invention relates to the use of nor-bile acids and their pharmaceutically acceptable salts, esters and/or derivatives in the treatment arteriosclerosis.
    Type: Application
    Filed: December 2, 2019
    Publication date: April 2, 2020
    Inventors: Tarek MOUSTAFA, Michael TRAUNER, Peter FICKERT
  • DIAGNOSIS OF STEATOHEPATITIS
    Publication number: 20150044673
    Abstract: The invention discloses the use of the methylation of the keratin 23 (KRT23) gene as a marker for distinguishing between steatosis and steatohepatitis.
    Type: Application
    Filed: December 21, 2012
    Publication date: February 12, 2015
    Inventors: Kurt Zatloukal, Karl Kashofer, Michael Trauner
  • Use of 24-nor-UDCA
    Patent number: 8951995
    Abstract: The present invention relates to the use of nor-ursodeoxycholic acid for the manufacture of a drug for the treatment and/or the prevention of liver diseases, preferably chronic liver diseases.
    Type: Grant
    Filed: May 12, 2005
    Date of Patent: February 10, 2015
    Assignee: Medizinische Universitat Graz
    Inventors: Michael Trauner, Alan Hofmann, Peter Fickert
  • USE OF NOR-BILE ACIDS IN THE TREATMENT OF ARTERIOSCLEROSIS
    Publication number: 20100311708
    Abstract: The present invention relates to the use of nor-bile acids and their pharmaceutically acceptable salts, esters and/or derivatives in the treatment arteriosclerosis.
    Type: Application
    Filed: July 24, 2008
    Publication date: December 9, 2010
    Inventors: Tarek Moustafa, Michael Trauner, Peter Fickert
  • Use of 24-nor-UDCA
    Publication number: 20090163459
    Abstract: The present invention relates to the use of nor-ursodeoxycholic acid for the manufacture of a drug for the treatment and/or the prevention of liver diseases, preferably chronic liver diseases.
    Type: Application
    Filed: May 12, 2005
    Publication date: June 25, 2009
    Applicant: MEDIZINISCHE UNIVERSITAT GRAZ
    Inventors: Michael Trauner, Alan Hofmann, Peter Fickert